demonstrated that YTHDF1 stabilizes E2F8 mRNA, which accelerates DNA damage repair and chemoresistance to adriamycin, cisplatin, and the PARP inhibitor olaparib in breast cancer cells (255). Here, YTHDF1 is linked to breast cancer.